However, DKK1, a WNT signaling inhibitor, exhibited a tissue‐dependent trend and context‐dependent pattern, revealing the multifaceted interplay between KRAS mutations and gene expression in CRC and PDAC. The gene discussed is KRAS; the disease is colorectal carcinoma.